| Immunoscintigraphy | |
|---|---|
| Purpose | detect cancer cells |
Immunoscintigraphy is a nuclear medicine procedure used to find cancer cells in the body by injecting a radioactively labeled antibody, which binds predominantly to cancer cells and then scanning for concentrations of radioactive emissions.
Clinical applications
Immunoscintigraphy is performed using a variety of radiopharmaceuticals, for a large range of purposes. Colorectal cancer is one of the most studied areas, with indium-111 or technetium-99m labelled epitopes of the carcinoembryonic antigen. The antibody capromab pendetide reacts with prostate membrane specific antigen (PMSA) and can be labelled with 111In.
See also
|
X-ray/ radiography |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRI | |||||||||||||
| Ultrasound | |||||||||||||
| Radionuclide |
|
||||||||||||
| Optical/Laser | |||||||||||||
| Thermography | |||||||||||||
| Target conditions | |||||||||||||
